Intra-Cellular Therapies Inc. buy BiotechBee
Start price
24.06.23
/
70%
€58.60
Target price
30.06.26
€90.00
Performance (%)
18.43%
End price
19.02.24
€69.40
Summary
This prediction ended on 19.02.24 with a price of €69.40. The prediction had a final performance of 18.43%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Intra-Cellular Therapies Inc. | - | - | - | - |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% | 53.697% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% | 76.697% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% | 60.793% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% | 62.807% |
According to BiotechBee what are the pros and cons of Intra-Cellular Therapies Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
In the thread Trading Intra-Cellular Therapies Inc.
Stopped prediction by BiotechBee for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€69.40
19.02.24
19.02.24
€85.00
30.09.25
30.09.25
15.27%
14.12.24
14.12.24
Could be very worthwhile Investment >20% year
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€44.49
23.09.22
23.09.22
€80.00
31.07.25
31.07.25
28.12%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year